Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP

Journal of Immunology

Volumn 174, Issue 5, 2005, Pages 2981-2989

  Lin, Phoebe ^a   Welch, Emily J ^a   Gao, Xiao Pei ^a   Malik, Asrar B ^a   Ye, Richard D ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; ALCOHOL; BOVINE SERUM ALBUMIN; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OXIDIZING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPID; PROTEIN KINASE B; PROTEIN P47 PHOX; PROTEIN P67 PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BLOOD VESSEL INJURY; CALCIUM MOBILIZATION; CAPILLARY PERMEABILITY; CELL FUNCTION; CELL VIABILITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; INFLAMMATION; ISOMER; LUNG BLOOD VESSEL; LUNG INJURY; LUNG PERFUSION; LUNG WEIGHT; MOUSE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; TISSUE INJURY; ULTRASOUND;

EID: 14044254805     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.5.2981     Document Type: Article

References (44)

1. Baggiolini, M., F. Boulay, J. A. Badwey, and J. T. Curnutte. 1993. Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J. 7:1004.
2. Snyderman, R., and R. J. Uhing. 1992. Phagocytic cells: stimulus-response coupling mechanisms. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman. eds. Raven Press, New York, p. 421.
3. Ye, R. D., and F. Boulay. 1997. Structure and function of the leukocyte chemoattractant receptors. Adv. Pharmacol. 39:221.
4. Albelda, S. M., C. W. Smith, and P. A. Ward. 1994. Adhesion molecules and inflammatory injury. FASEB J. 8:504.
5. Hallett, M. B., and D. Lloyds. 1995. Neutrophil priming: the cellular signals that say 'amber' but not 'green.' Immunol. Today 16:264.
6. Subbaiah, P. V., C. H. Chen, J. D. Bagdade, and J. J. Albers. 1985. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J. Biol. Chem. 260:5308.
7. +-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 43:915.
8. Prokazova, N. V., N. D. Zvezdina, and A. A. Korotaeva. 1998. Effect of lysophosphatidylcholine on transmembrane signal transduction. Biochemistry 63:31.
9. Parthasarathy, S., U. P. Steinbrecher, J. Barnett, J. L. Witztum, and D. Steinberg. 1985. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA 82:3000.
10. Quinn, M. T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA 85:2805.
11. Radu, C. G., L. V. Yang, M. Riedinger, M. Au, and O. N. Witte. 2004. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc. Halt. Acad. Sci. USA 101:245.
12. Lauber, K., E. Bohn, S. M. Krober, Y. J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717.
13. Ginsburg, I., P. A. Ward, and J. Varani. 1989. Lysophosphatides enhance superoxide responses of stimulated human neutrophils. Inflammation 13:163.
14. Silliman, C. C., D. J. Elzi, D. R. Ambruso, R. J. Musters, C. Hamiel, R. J. Harbeck, A. J. Paterson, A. J. Bjornsen, T. H. Wyman, M. Kelher, et al. 2003. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukocyte Biol. 73:511.
15. Muller, J., M. Petkovic, J. Schiller, K. Arnold, S. Reichl, and J. Arnhold. 2002. Effects of lysophospholipids on the generation of reactive oxygen species by fMLP- and PMA-stimulated human neutrophils. Luminescence 17:141.
16. Lin, P., and R. D. Ye. 2003. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J. Biol. Chem. 278:14379.
17. Fantozzi, R., S. Brunelleschi, P. Cremonesi, P. G. Pagella, D. Ciani, and G. C. Sportoletti. 1985. Drug modulation of superoxide anion production from human neutrophils. Int. J. Tissue React. 7:149.
18. Nielson, C. P., R. E. Vestal, R. S. Sturm, and R. Heaslip. 1990. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol. 86:801.
19. Gibson-Berry, K. L., J. C. Whitin, and H. J. Cohen. 1993. Modulation of the respiratory burst in human neutrophils by isoproterenol and dibutyryl cyclic AMP. J. Neuroimmunol. 43:59.
20. al-Essa, L. Y., M. Niwa, K. Kohno, M. Nozaki, and K. Tsurumi. 1995. Heterogeneity of circulating and exudated polymorphonuclear leukocytes in superoxide-generating response to cyclic AMP and cyclic AMP-elevating agents: investigation of the underlying mechanism. Biochem. Pharmacol. 49:315.
21. Lundqvist, H., and C. Dahlgren. 1996. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radical Biol. Med. 20:785.
22. Lo, S. K., B. Bevilacqua, and A. B. Malik. 1994. E-selectin ligands mediate tumor necrosis factor-induced neutrophil sequestration and pulmonary edema in guinea pig lungs. Circ. Res. 75:955.
23. Gao, X., P. Kouklis, N. Xu, R. D. Minshall, R. Sandoval, S. M. Vogel, and A. B. Malik. 2000. Reversibility of increased microvessel permeability in response to VE-cadherin disassembly. Am. J. Physiol. 279:11218.
24. He, R., H. Sang, and R. D. Ye. 2003. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101:1572.
25. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484.
26. Wittmann, S., G. Rome, G. Schmitz, and D. Frohlich. 2004. Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response. Cytometry 57A:53.
27. phox by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry 42:4520.
28. phox and mediates respiratory burst activity in human neutrophils. J. Immunol. 170:5302.
29. Rane, M. J., S. L. Carrithers, J. M. Arthur, J. B. Klein, and K. R. McLeish. 1997. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase. J. Immunol. 159:5070.
30. Chin, K. V., W. L. Yang, R. Ravatn, T. Kita, E. Reitman, D. Vettori, M. E. Cvijic, M. Shin, and L. Iacono. 2002. Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling. Ann. NY Acad. Sci. 968:49.
31. 2+ signaling via the platelet-activating factor receptor in macrophages. Am. J. Physiol. 272:H17.
32. Huang, Y. H., L. Schafer-Elinder, R. Wu, H. E. Claesson, and J. Frostegard. 1999. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin. Exp. Immunol. 116:326.
33. Takahara, N., A. Kashiwagi, H. Maegawa, and Y. Shigeta. 1996. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45:559.
34. Kabarowski, J. H., K. Zhu, L. Q. Le, O. N. Witte, and Y. Xu. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293:702.
35. Marathe, G. K., A. R. Silva, H. C. de Castro Faria Neto, L. W. Tjoelker, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 2001. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. J. Lipid Res. 42:1430.
36. Sullivan, G. W. 2003. Adenosine A2A receptor agonists as anti-inflammatory agents. Curr. Opin. Invest. Drugs 4:1313.
37. Yuan, Y., S. M. Schoenwaelder, H. H. Salem, and S. P. Jackson. 1996. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. J. Biol. Chem. 271:27090.
38. Engelmann, B., S. Zieseniss, K. Brand, S. Page, A. Lentschat, A. J. Ulmer, and E. Gerlach. 1999. Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. Arterioscler Thromb Vasc. Biol. 19:47.
39. Drobnik, W., G. Liebisch, F. X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz. 2003. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J. Lipid. Res. 44:754.
40. Yan, J. J., J. S. Jung, J. E. Lee, J. Lee, S. O. Huh, H. S. Kim, K. C. Jung, J. Y. Cho, J. S. Nam, H. W. Suh, et al. 2004. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat. Med. 10:161.
41. Van Dyke, T. E., and C. N. Serhan. 2003. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82:82.
42. Kabarowski, J. H., J. D. Feramisco, L. Q. Le, J. L. Gu, S. W. Luoh, M. I. Simon, and O. N. Witte. 2000. Direct genetic demonstration of Gα13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement. Proc. Natl. Acad. Sci. USA 97:12109.
43. Zhu, K., L. M. Baudhuin, G. Hong, F. S. Williams, K. L. Cristina, J. H. Kabarowski, O. N. Witte, and Y. Xu. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276:41325.
44. Lum, H., J. Qiao, R. J. Walter, F. Huang, P. V. Subbaiah, K. S. Kim, and O. Holian. 2003. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am. J. Physiol. 285:H1786.